{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:38:25Z","timestamp":1782743905751,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ophtha.2011.09.004","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T18:19:32Z","timestamp":1323368372000},"page":"588-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Intravitreal Ganciclovir Maintenance Injection for Cytomegalovirus Retinitis: Efficacy of a Low-Volume, Intermediate-Dose Regimen"],"prefix":"10.1016","volume":"119","author":[{"given":"Stephen C.","family":"Teoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tock H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2011.09.004_bib1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine","volume":"166","author":"Gallant","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2011.09.004_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9394(14)70778-0","article-title":"Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5","volume":"124","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9394(14)71453-9","article-title":"Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome","volume":"115","author":"Kuppermann","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib4","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ophtha.2011.09.004_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ophtha.2006.07.065","article-title":"Longitudinal study of the ocular complications of AIDS","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.004_bib6","first-page":"50","article-title":"World Health Statistics 2009","year":"2009"},{"key":"10.1016\/j.ophtha.2011.09.004_bib7","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0161-6420(91)32135-3","article-title":"Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome","volume":"98","author":"Cochereau-Massin","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.004_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.5694\/j.1326-5377.1992.tb137242.x","article-title":"High dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitis","volume":"157","author":"Young","year":"1992","journal-title":"Med J Aust"},{"issue":"RR-17","key":"10.1016\/j.ophtha.2011.09.004_bib9","first-page":"1","article-title":"1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ophtha.2011.09.004_bib10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-103-3-377","article-title":"Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine","volume":"103","author":"Felsenstein","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2011.09.004_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-6420(89)32900-9","article-title":"Treatment of cytomegalovirus retinitis with intravitreal ganciclovir: long-term results","volume":"96","author":"Cantrill","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.004_bib12","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/archopht.1989.01070020849025","article-title":"Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy","volume":"107","author":"Heinemann","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0161-6420(88)33147-7","article-title":"Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis","volume":"95","author":"Ussery","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.004_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/00912709922008452","article-title":"Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects","volume":"39","author":"Jung","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/106002809603000701","article-title":"Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS","volume":"30","author":"Montero","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ophtha.2011.09.004_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/bjo.80.3.214","article-title":"High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration","volume":"80","author":"Morlet","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib17","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/infdis\/168.6.1506","article-title":"Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy","volume":"168","author":"Kuppermann","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2011.09.004_bib18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa011759","article-title":"A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2011.09.004_bib19","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial","volume":"112","author":"Martin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s100960100508","article-title":"Influence of the response to induction therapy on the rate of progression of cytomegalovirus retinitis in AIDS patients on intravitreal maintenance therapy","volume":"20","author":"L\u00fapez-Cort\u00e9s","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ophtha.2011.09.004_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0161-6420(87)33534-1","article-title":"Treatment of cytomegalovirus retinopathy with ganciclovir","volume":"94","author":"Holland","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.09.004_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archopht.1989.01070010077031","article-title":"Cytomegalovirus retinitis and acquired immunodeficiency syndrome","volume":"107","author":"Jabs","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib23","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome","volume":"107","author":"Holland","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/168.3.557","article-title":"A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS","volume":"168","author":"Spector","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2011.09.004_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jmv.1890250311","article-title":"Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis","volume":"25","author":"Jacobson","year":"1988","journal-title":"J Med Virol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib26","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archopht.1996.01100140029003","article-title":"Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis","volume":"114","author":"Marx","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ajo.2005.01.005","article-title":"Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis","volume":"139","author":"Kempen","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9394(98)00443-7","article-title":"Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis","volume":"127","author":"Lim","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004170050319","article-title":"Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis","volume":"237","author":"Guembel","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.09.004_bib30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/archopht.121.11.1586","article-title":"Use of best and final visual acuity outcomes in ophthalmological research","volume":"121","author":"DiLoreto","year":"2003","journal-title":"Arch Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011008396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011008396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:01:39Z","timestamp":1758981699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642011008396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0161642011008396"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.004","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Ganciclovir Maintenance Injection for Cytomegalovirus Retinitis: Efficacy of a Low-Volume, Intermediate-Dose Regimen","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}